Alder is a biopharmaceutical company committed to transforming migraine treatment through the discovery, development and commercialization of novel therapeutic antibodies. The company’s mission is to forever change migraine treatment and give people with migraine their lives back. Alder knows the physical and emotional toll migraine can take not just on the individual but also those who care for them. In fact, some of our employees suffer from migraine themselves. To Alder, people with migraine are not “nameless” subjects or data points, but friends, family, and others whose stories motivate Alder to do its best work. The team’s insight into the needs of migraine patients has enabled us to leverage our monoclonal antibody expertise to design best-in-class therapies.